62 related articles for article (PubMed ID: 17970769)
1. Asymptomatic bilateral adrenal pheochromocytoma in a patient with a germline V804M mutation in the RET proto-oncogene.
Pinna G; Ghiani M; Mariotti S
Clin Endocrinol (Oxf); 2008 May; 68(5):836. PubMed ID: 17970769
[No Abstract] [Full Text] [Related]
2. Asymptomatic bilateral adrenal pheochromocytoma in a patient with a germline V804M mutation in the RET proto-oncogene.
Recasens M; Oriola J; Fernández-Real JM; Roig J; Rodríguez-Hermosa JI; Font JA; Galofre P; López-Bermejo A; Ricart W
Clin Endocrinol (Oxf); 2007 Jul; 67(1):29-33. PubMed ID: 17466010
[TBL] [Abstract][Full Text] [Related]
3. Pheochromocytoma penetrance varies by RET mutation in MEN 2A.
Machens A; Dralle H
Surgery; 2008 May; 143(5):696; author reply 697. PubMed ID: 18436021
[No Abstract] [Full Text] [Related]
4. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.
Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L
Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172
[TBL] [Abstract][Full Text] [Related]
5. The genetic basis of pheochromocytoma: who to screen and how?
Plouin PF; Gimenez-Roqueplo AP
Nat Clin Pract Endocrinol Metab; 2006 Feb; 2(2):60-1. PubMed ID: 16932255
[No Abstract] [Full Text] [Related]
6. [Pheochromocytoma].
Arai H; Nakao K
Nihon Rinsho; 2006 May; Suppl 1():724-9. PubMed ID: 16776260
[No Abstract] [Full Text] [Related]
7. A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional characterization.
Castellone MD; Verrienti A; Magendra Rao D; Sponziello M; Fabbro D; Muthu M; Durante C; Maranghi M; Damante G; Pizzolitto S; Costante G; Russo D; Santoro M; Filetti S
Clin Endocrinol (Oxf); 2010 Oct; 73(4):529-34. PubMed ID: 20039896
[TBL] [Abstract][Full Text] [Related]
8. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
Oliveira MN; Hemerly JP; Bastos AU; Tamanaha R; Latini FR; Camacho CP; Impellizzeri A; Maciel RM; Cerutti JM
Thyroid; 2011 Sep; 21(9):975-85. PubMed ID: 21834681
[TBL] [Abstract][Full Text] [Related]
9. One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C?
Shifrin AL; Xenachis C; Fay A; Matulewicz TJ; Kuo YH; Vernick JJ
Surgery; 2009 Dec; 146(6):998-1005. PubMed ID: 19958926
[TBL] [Abstract][Full Text] [Related]
10. Questioning the pathogenic role of the pTyr791Phe mutation of the RET proto-oncogene: Insight from a case report.
Mavromati M; Amsallem M; Jublanc C; Bruckert E; Leenhardt L; Girerd X
Ann Endocrinol (Paris); 2015 Dec; 76(6):690-4. PubMed ID: 26639185
[TBL] [Abstract][Full Text] [Related]
11. Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients.
Cascón A; Inglada-Pérez L; Comino-Méndez I; de Cubas AA; Letón R; Mora J; Marazuela M; Galofré JC; Quesada-Charneco M; Robledo M
Endocr Relat Cancer; 2013 Jun; 20(3):L1-6. PubMed ID: 23404858
[No Abstract] [Full Text] [Related]
12. Molecular implications of RET mutations for pheochromocytoma risk in multiple endocrine neoplasia 2.
Gujral TS; Mulligan LM
Ann N Y Acad Sci; 2006 Aug; 1073():234-40. PubMed ID: 17102091
[TBL] [Abstract][Full Text] [Related]
13. [Mutation screening of RET proto-oncogene in Chinese sporadic patients with pheochromocytoma].
Han ZY; Qiu CG; Chen QH; Zhu Y; Zhu DL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):320-2. PubMed ID: 16767674
[TBL] [Abstract][Full Text] [Related]
14. Pheochromocytoma penetrance varies by RET mutation in MEN 2A.
Quayle FJ; Fialkowski EA; Benveniste R; Moley JF
Surgery; 2007 Dec; 142(6):800-5; discussion 805.e1. PubMed ID: 18063059
[TBL] [Abstract][Full Text] [Related]
15. RET expression and neuron-like differentiation of pheochromocytoma and normal chromaffin cells.
Powers JF; Picard KL; Tischler AS
Horm Metab Res; 2009 Sep; 41(9):710-4. PubMed ID: 19551609
[TBL] [Abstract][Full Text] [Related]
16. Multiple endocrine neoplasia type 2 (MEN 2).
Frank-Raue K; Raue F
Eur J Cancer; 2009 Sep; 45 Suppl 1():267-73. PubMed ID: 19775624
[No Abstract] [Full Text] [Related]
17. Simultaneous medullary and papillary thyroid carcinomas in carriers of the V804M RET germline mutation-a spurious association?
Machens A; Dralle H
Surgery; 2010 Jun; 147(6):895-6; author reply 896-7. PubMed ID: 20494215
[No Abstract] [Full Text] [Related]
18. Bilateral pheochromocytoma during the postpartum period.
Wattanachanya L; Bunworasate U; Plengpanich W; Houngngam N; Buranasupkajorn P; Sunthornyothin S; Shotelersuk V; Snabboon T
Arch Gynecol Obstet; 2009 Dec; 280(6):1055-8. PubMed ID: 19340440
[TBL] [Abstract][Full Text] [Related]
19. Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside.
Machens A; Dralle H
Mol Cell Endocrinol; 2006 Mar; 247(1-2):34-40. PubMed ID: 16343738
[TBL] [Abstract][Full Text] [Related]
20. Penetrance of phaeochromocytoma in
Maciel RMB; Bim LV; Camacho CP; Cerutti JM
Endocr Relat Cancer; 2018 Sep; 25(9):L49-L51. PubMed ID: 30012587
[No Abstract] [Full Text] [Related]
[Next] [New Search]
